Alcohol Use, UnspecifiedNCT06401967
Study of a Smartphone-Based Alcohol Reduction Program
A study testing Pivot Clear and BACtrack breathalyzer in people with Alcohol Use, Unspecified, run by Pivot Health Technologies Inc. at 1 site in United States.
Trial summary
Prospective, open label, single center clinical study enrolling up to 100 adult participants to evaluate the feasibility, acceptability, and preliminary outcomes of the Pivot Clear smartphone-based alcohol reduction program. Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- Alcohol Use, Unspecified
- What is being tested?
- Pivot Clear and BACtrack breathalyzer
- Type of treatment
- Medical device, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteUnited States
- Study dates
- Jun 2024to Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Score of ≥ 3 for women and ≥ 4 for men on the AUDIT-C at screening
- Would like to reduce or eliminate alcohol consumption
- Resident of the United States
- Able to read and comprehend English
- Owns and uses a smartphone compatible with the study app (iPhone 6 and above, operating system iOS (iPhone operating system) 15 and above, or Android 7.0 and above, operating system Android 7.0 and above)
- Has daily internet access on smartphone
Show all 9Show fewer
- Comfortable downloading and using smartphone apps
- Interested in working with an alcohol reduction coach via SMS text
- Willing to sign the Informed Consent Form (ICF)
Who cannot join
- Currently using other support to reduce or quit alcohol, including apps, coaching, support groups, classes or quit programs
- Pregnant (self-reported)
- Self-reported past or present diagnosis of Alcohol Use Disorder (AUD)
- Self-reported past or present diagnosis of Substance Use Disorder
- Current use of the following medications: suboxone, methadone, or daily use of a benzodiazepine [including Alprazolam (e.g., Xanax), lorazepam (e.g., Ativan), clonazepam (e.g., Klonopin), diazepam (e.g., Valium), and temazepam (e.g., Restoril)]
- History of hospitalization or in-patient treatment due to alcohol use
Show all 9Show fewer
- Using other alcohol reduction or abstinence apps, coaching, support groups, classes, or programs at study entry
- Failure to provide contact or collateral information, and/or failure to verify email address
- Participation in a previous study sponsored by Pivot Health Technologies, Inc. (formerly Carrot Inc.)
Trial locations and contacts
1 site in 1 country.
United States1 site
Pivot Health Technologies, Inc.
San Carlos, California, 94070
About this study
Official title: Feasibility, Acceptability, and Preliminary Outcomes of a Smartphone-Based Program for Reduction in Alcohol Consumption
Prospective, open label, single center clinical study enrolling up to 100 adult participants to evaluate the feasibility, acceptability, and preliminary outcomes of the Pivot Clear smartphone-based alcohol reduction program.
Read the detailed description
This is a prospective, open label, single center clinical study conducted with institutional review board (IRB) approval enrolling up to 100 adult participants who report at-risk alcohol consumption behavior and would like to reduce or eliminate alcohol consumption. The study will be performed remotely on an ambulatory basis. Participants will be asked to set up and use the Pivot Clear program. The program includes an app, personal breathalyzer, and short message service (SMS) text-based coaching with an alcohol reduction specialist. The study duration is 52 weeks. While participants will have access to the program for 52 weeks, it is expected that for most participants, most active participation in the program will be complete by 12 weeks. The primary reporting time point will be 12 weeks, with expected passive, longer-term follow-up outcomes collected at 26 weeks and 52 weeks. Participants will receive online questionnaires at intervals throughout the study (baseline, weekly for the first 12 weeks, at 26 weeks and at 52 weeks).
- Conditions
- Alcohol Use, Unspecified
- Being tested
- Pivot Clear, BACtrack breathalyzer
- Keywords
- alcohol reduction, digital health, mobile apps, health promotion
- Medical subject headings
- Alcohol Drinking
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pivot ClearBehavioural
A mobile app and program for alcohol reduction.
BACtrack breathalyzerDevice
Personal breathalyzer device that measures blood alcohol content.
| Study group | Role | What they receive |
|---|---|---|
| Pivot Clear | Experimental | A program for alcohol reduction Receives: Behavioral: Pivot Clear; Device: BACtrack breathalyzer |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of participants who complete all 12 weekly follow-up assessments
Calculated as the number of participants who complete 12/12 of the weekly follow-up assessments (specifically during the first 12 weeks of the study), divided by the total number of enrolled participants.
Measured: 12 weeks
Secondary outcomes (50)
Trial feasibility - enrollment
Trial feasibility is assessed with multiple measures of enrollment success; all are the percentage of potential participants that remain eligible after each pre-enrollment step.
- The percent of potential participants who complete the online screening that are eligible for participation.
- The percent of potential participants who complete the eligibility phone call that are eligible for participation.
- The percent of potential participants who remain eligible after the screening call who consent and complete study enrollment (study enrollment includes: electronically signing the informed consent form, completing the baseline questionnaire, and completing registration in the app).
Measured: Baseline
Trial feasibility - questionnaire completion
Trial feasibility is assessed with measuring the percent of enrolled participants who complete at least 80% of all study questionnaires.
Measured: 52 weeks
Average weekly alcohol consumption
Reported as the mean number of standard drinks per week over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.
Measured: 1-12, 26, and 52 weeks
Proportion of participants with average drinks per day ≤ 2/day for men and ≤ 1/day for women
Based on the average weekly alcohol consumption which is reported as the mean number of standard drinks per week over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.
Calculated as the number of participants with average drinks per day ≤ 2/day for men and ≤ 1/day for women over the specified time period, divided by the total number of enrolled participants.
Measured: 1-12, 26, and 52 weeks
Proportion of participants who complied with the low-risk guideline for problematic drinking
The low-risk guideline for problematic drinking is defined as having consumed no more than 7 drinks per week and no more than 3 drinks on any single day (for women), or 14 drinks per week and no more than 4 drinks on any single day (for men).
Based on the average weekly alcohol consumption which is reported as the mean number of standard drinks per week over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.
Calculated as the number of participants meeting the above low-risk guideline criteria over the specified time period, divided by the total number of enrolled participants.
Measured: 1-12, 26, and 52 weeks
Average daily alcohol consumption
Reported as the mean number of standard drinks per day over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.
Measured: 1-12, 26, and 52 weeks
Average drinks per drinking day
Reported as the mean number of standard drinks per drinking day (excluding days where no drinks were consumed) over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method.
Measured: 1-12, 26, and 52 weeks
Proportion of participants with an AUDIT-C score below the threshold for unhealthy alcohol use in the U.S.
AUDIT-C = Alcohol Use Disorders Identification Test-Consumption (the first three questions from the 10-item AUDIT, a tool developed by the World Health Organization to evaluate a person's use of alcohol).
AUDIT-C scores range from 0 to 12 points, and are a sum of scores for each of its 3 questions. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Unhealthy alcohol use in the U.S. is defined as a score greater than 4 for men, and a score greater than 3 for women.
The number of individuals that have AUDIT-C scores below these thresholds will be divided by the total number of participants to obtain this outcome proportion.
Measured: 12, 26, and 52 weeks
Proportion of participants who reduced their AUDIT-C score category by by ≥ 1 risk level
AUDIT-C = Alcohol Use Disorders Identification Test-Consumption.
AUDIT-C scores range from 0 to 12 points, and are a sum of scores for each of its 3 questions. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Unhealthy alcohol use in the U.S. is defined as a score greater than 4 for men, and a score greater than 3 for women.
AUDIT-C scores can also be categorized into four risk levels: 0-4 indicates lower risk, 5-7 indicates increasing risk, 8-10 indicates higher risk, and 11 to 12 indicates possible dependence. An example of reducing by one risk level: a change from a score of 6, "increasing risk", at baseline to a score of 3, "lower risk", at follow-up.
The number of individuals that reduce their AUDIT-C score category by at least one risk level will be divided by the total number of participants to obtain this outcome proportion.
Measured: 12, 26, and 52 weeks
Proportion of participants with an AUDIT score within the "lower risk" category
AUDIT = Alcohol Use Disorders Identification Test (10-items, a tool developed by the World Health Organization to evaluate a person's use of alcohol).
AUDIT scores range from 0 to 40 points. The score is a sum of scores for its 10 questions, each of which range from 0 to 4. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Scores of 8 and greater are suggestive of an alcohol problem.
AUDIT scores can also be categorized into four risk levels: 0-7 indicates lower risk, 8-15 indicates increasing risk, 16-19 indicates higher risk, and 20+ indicates possible dependence. An example of reducing by one risk level: a change from a score of 9, "increasing risk", at baseline to a score of 5, "lower risk", at follow-up.
The number of individuals that have AUDIT scores of 7 or lower will be divided by the total number of participants to obtain this outcome proportion.
Measured: 12, 26, and 52 weeks
Proportion of participants who reduced their AUDIT score category by by ≥ 1 risk level
AUDIT = Alcohol Use Disorders Identification Test (10-items, a tool developed by the World Health Organization to evaluate a person's use of alcohol).
AUDIT scores range from 0 to 40 points. The score is a sum of scores for its 10 questions, each of which range from 0 to 4. Lower scores indicate less alcohol use; higher scores indicate greater alcohol use. Scores of 8 and greater are suggestive of an alcohol problem.
AUDIT scores can also be categorized into four risk levels: 0-7 indicates lower risk, 8-15 indicates increasing risk, 16-19 indicates higher risk, and 20+ indicates possible dependence. An example of reducing by one risk level: a change from a score of 9, "increasing risk", at baseline to a score of 5, "lower risk", at follow-up.
The number of individuals that reduce their AUDIT score category by at least one risk level will be divided by the total number of participants to obtain this outcome proportion.
Measured: 12, 26, and 52 weeks
Number of heavy drinking days
Heavy drinking days are defined as days with ≥ 5 drinks for men and ≥ 4 drinks for women.
Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.
The number of heavy drinking days will be determined by counting the number of days of heavy drinking within each follow-back period.
Measured: 1-12, 26, and 52 weeks
Maximum number of drinks on any day over the timeline follow-back period
Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.
The maximum number of drinks will be determined over the 7-day follow-back periods for weeks 1-12, and the 28-day follow-back periods for weeks 26 and 52.
Measured: 1-12, 26, and 52 weeks
Proportion of days abstinent
Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.
Proportion of days abstinent will be calculated as number of days where 0 drinks were reported that day, out of the total number of days in that follow-back period (7 or 28).
Measured: 1-12, 26, and 52 weeks
Average duration of continuous abstinence
Based on the timeline follow-back (TLFB) calendar method; 7-day follow-back for weeks 1-12 and 28-day follow-back for weeks 26 and 52.
Calculated as the average number of consecutive days where 0 drinks were reported on the timeline follow-back.
Measured: 12, 26, and 52 weeks
Proportion of participants who reduced their World Health Organization (WHO) risk drinking level by ≥ 1 risk level
The WHO risk drinking levels are defined as follows:
low risk = 0 to 2.9 drinks/day (men) and 0 to 1.4 drinks/day (women) medium risk = 3.0 to 4.3 drinks/day (men) and 1.5 to 2.8 drinks/day (women) high risk = 4.4 to 7.1 drinks/day (men) and 2.9 to 4.3 drinks/day (women) very high risk = 7.2+ drinks/day (men) and 4.4+ drinks/day (women)
Based on the average daily alcohol consumption which is reported as the mean number of standard drinks per day over the past 7-28 days, based on the timeline follow-back (TLFB) calendar method. Example of reducing one drinking level: a woman decreasing from an average of 3 drinks per day (high risk) to an average of 2 drinks per day (medium risk).
The number of individuals that reduce their WHO risk drinking level by at least one level will be divided by the total number of participants to obtain this outcome proportion.
Measured: 12, 26, and 52 weeks
Adverse consequence related to alcohol
Adverse consequence related to alcohol are assessed via the short inventory of problems revised (SIP-R), a15-item measure. The 15 items are rated on a 4-point scale (from 0-3); 0 = Never, 1 = Once or a few times, 2 = Once or twice a week, 3 = Daily or almost daily.
Scores for the SIP-R range from 0 to 45, where a higher score indicates experience with greater adverse consequences related to alcohol.
Measured: 12, 26, and 52 weeks
Drinking motivations
Drinking motivations are assessed via the Drinking Motivation Questionnaire Revised (DMQR, 20 items). The 20 items are rated on a 5-point Likert scale (from 1-5); 1 = Almost Never/Never, 2 = Some of the time, 3 = Half of the time, 4 = Most of the time, 5 = Almost Always/Always.
This scale has 5 items each for reflecting the following four categories of motives: social, coping, enhancement, and external social pressures.
The DMQR yields four scale scores (between 5 and 25) reflecting each of these motives for drinking alcohol, where a higher score indicates greater frequency of the reason motivating them to drink alcohol.
Measured: 12, 26, and 52 weeks
Desire to change drinking habits
Participants are asked: "Do you have any desire to change your drinking habits?"
With the following options to answer:
- No, I'm comfortable with my current habits
- No, I know I could drink a little less but I'm not motivated to change right now
- Yes, I'm interested in drinking a little less
- Yes, I'm interested in drinking a lot less
- Yes, I'm interested in stopping drinking for a short period of time
- Yes, I'm interested in stopping drinking for a long period of time
Measured: Baseline
Reasons for desired change in drinking habits
Participants are asked: "What are your reasons for wanting to change your drinking?" The following options are provided (participants select all that apply): physical health/disease prevention or disease management, physical wellness/fitness, spend less money, diet/reduce calorie intake, mental health, mindfulness goals, relationship improvement, work/career improvement, or other (please describe).
Participants are then asked to rank the selected options starting at 1 = Most important (ending at the number of reasons that were selected).
Measured: Baseline
Readiness to change
Participants are asked: "How ready are you to make changes to your drinking habits?" Answered on a range from 1-10; 1 = not at all ready, 10 = extremely ready. A higher score indicates greater readiness to change drinking habits.
Measured: 4 and 12 weeks
Expected success to change drinking habits
Participants are asked: "If you were to change your drinking habits now, how successful would you be?" Answered on a range from 1-10; 1 = not at all successful, 10 = extremely successful. A higher score indicates greater expected success in changing drinking habits.
Measured: 4 and 12 weeks
Expected difficulty maintaining reduction/abstinence
Participants are asked: "If you were to change your drinking habits now, how difficult do you think it would be to keep your new habits?" Answered on a range from 1-10; 1 = not difficult at all, 10 = extremely difficult. A higher score indicates greater expected difficulty to change drinking habits.
Measured: 4 and 12 weeks
Satisfaction with current drinking behavior
Participants are asked: "How satisfied are you with your current drinking behavior?" Answered on a range from 1-10; 1 = not at all satisfied, 10 = very satisfied. A higher score indicates greater satisfaction with current drinking behavior.
Measured: 12, 26, and 52 weeks
User feedback - set up and getting started with the program
Assessed with the following question: "How easy or difficult was it to set-up and get started in the Pivot program?" Participants answer on a 1-10 scale; 1 = very difficult, 10 = very easy. A higher score indicates an easier time setting up and getting started with the program.
Measured: 4 weeks
User satisfaction - Net Promoter Score
Specifically regarding likelihood to recommend to a friend or colleague, Net Promoter Score (NPS). Participants are asked: "How likely would you be to recommend the Pivot Clear program to a friend or colleague that had a desire to drink less?" Answered on a range from 1-10; 1 = not at all likely, 10 = very likely. A higher score indicates greater user satisfaction and promotion of the program.
Measured: 4, 12, and 26 weeks
User satisfaction - how use of the program has affected alcohol consumption
Participants are asked: "How has using the Pivot program affected your alcohol consumption?"
Participants are provided with the following options to choose from:
- Using the program has increased my alcohol consumption
- Using the program has not affected my alcohol consumption
- Using the program has decreased my alcohol consumption
Measured: 5 weeks
User satisfaction - effectiveness of the program
Participants are asked: "Did you find the Pivot Clear program effective so far?".
Participants are provided 4 choices to answer: very effective, somewhat effective, not really effective, not at all effective
Measured: 12 weeks
User satisfaction - whether the program helped the participant maintain alcohol reduction
Participants are presented with the following statement: "The program has helped me maintain a new drinking level where I drink less than when I started the study." Participants are asked to select True/False.
Measured: 12, 26, and 52 weeks
User satisfaction - program's ability to help someone reduce or quit alcohol
Participants are asked: "Which of the following best describes the Pivot Clear program's ability to help someone reduce or quit alcohol?"
Participants are provided the following options to choose from:
- The program is extremely helpful
- The program is helpful
- The program does not affect being able to reduce or quit alcohol
- The program makes reducing or quitting alcohol more difficult
Measured: 10 weeks
User satisfaction - perceived need for the program
Participants are asked: "Which of the following best describes your need for the Pivot Clear program".
Participants are provided the following options to choose from:
- I really need this program
- I somewhat need this program
- I don't need this program
- I am not at all interested in this program
Measured: 4 weeks
User satisfaction - effect of program on motivation to reduce/abstain
Participants are asked: "How has using the Pivot program affected your motivation to change your drinking habits?"
Participants are provided with the following options to choose from:
- Using the program has increased my motivation to change my drinking habits
- Using the program has not affected my motivation to change my drinking habits
- Using the program has decreased my motivation to change my drinking habits
Measured: 3 weeks
User feedback - initial reactions to program design, specific program features including the breathalyzer, coaching, lessons, and drink tracking
Participants are asked: "What best describes your initial reaction to finding out a [breathalyzer; coach; drink tracker] was a part of this program?"
Participants are provided the following to choose from:
- I thought it was out of place in the program as I think it is [a legal/compliance/negative tool for; a substance abuse counselor for; only used by] those with a severe drinking problem
- I don't think it is necessary or helpful
- I was curious about it and didn't have strong feelings
- Made sense to me as this was a program related to [alcohol, behavior change, alcohol consumption behavior]
- I was very interested to use it
Measured: 1 week
User feedback - program design, specific program features including the breathalyzer, coaching, lessons, and drink tracking
Participants are asked various questions regarding program features and design.
Participants are asked: "Have you gained any insights from your [initial use of the breathalyzer; initial interactions with the drink tracker in the Pivot app; initial interactions with the coach; interactions with the lessons]? Check all that apply."
Participants are provided the following options to choose:
- Not applicable
- Not really
- It confirmed what I already thought
- It was motivating
- It was demotivating
- It triggered me to drink more
- It triggered me to drink less
Measured: 2, 3, 5, and 12 weeks
User satisfaction - aspects of program participant enjoyed most/least
Participants are asked: "What aspect of the program do you enjoy the most so far?" and "What aspect of the program do you enjoy the least so far?".
For both questions they are provided the following to choose from:
- Coaching
- Tracker
- Lessons
- Breathalyzer
- Other app contents/features (please specify)
Measured: 12 weeks
User feedback - possible future program features
Participants are asked about potential future program features (small interest groups, breathalyzer connected to the app, text-based community, coaching via phone calls).
They are provided the following to choose from:
- Very interested
- Somewhat interested
- Probably not interested
- Definitely not interested
- Comments (optional)
Measured: 12 weeks
Use of other alcohol reduction or abstinence tools (apps, counseling, medications, etc.)
Assessed via self-report. Participants are asked about other alcohol reduction or abstinence tools they have used throughout the last 6 months. Tools asked about include: apps (other than Pivot), counseling, medications, acupuncture, hypnotherapy, etc. Participants can report other tools not included in the list provided. Outcome reported as the number of participants who have used each other alcohol reduction or abstinence tools.
Measured: 11, 26, and 52 weeks
Engagement with the program - app openings
Collected via back-end app data collection. Engagement is specifically assessed with number of times the Pivot app was opened (number of app openings), number of days the app was opened, and the number of weeks the app was opened. All are assessed over the first 26 weeks of study enrollment.
Measured: 26 weeks
Engagement with program - number of days with app openings
Collected via back-end app data collection. Engagement is specifically assessed with the number of days over which the app was opened by participants over the first 26 weeks of study enrollment.
Measured: 26 weeks
Engagement with program - number of weeks with app openings
Collected via back-end app data collection. Engagement is specifically assessed with the number of weeks over which the app was opened by participants over the first 26 weeks of study enrollment.
Measured: 26 weeks
Engagement with program - average duration of app sessions
Collected via back-end app data collection. Engagement is specifically assessed with the average duration of app sessions completed by participants over the first 26 weeks of study enrollment. Outcome unit of measure = duration in minutes.
Measured: 26 weeks
Engagement with program - use of app features
Collected via back-end app data collection. Engagement is specifically assessed with the use of app features (Lessons, Drink Logging, Crush a Craving, Challenges/Triggers, Goal Setting) by participants over the first 26 weeks of study enrollment. Reported as the number of times each app feature was used.
Measured: 26 weeks
Engagement with program - average number of messages
Collected via back-end app data collection. Engagement is specifically assessed with average number of messages sent by coach to participant per week and average number of messages sent by participant to coach per week, over the first 26 weeks of study enrollment.
Measured: 26 weeks
Engagement with program - average number of weeks with coach engagement
Collected via back-end app data collection. Specifically, the average number of weeks with at least one message sent from participant to coach over the first 26 weeks of study enrollment.
Measured: 26 weeks
Change in ratings of self-reported health indicators
The following health indicators are assessed: sleep quality, nutrition/diet quality, weight management, ability to manage stress, physical fitness, mental health (anxiety, depression, bipolar as applicable), and chronic diseases (cardiovascular disease, diabetes, high blood pressure, asthma, COPD, acid reflux as applicable).
COPD = chronic obstructive pulmonary disease
Participants are asked to rate each of the above health indicators on a scale of 1-5; 1 = poor, 5 = excellent.
Ratings at each timepoint are compared to the baseline score to determine their change.
Measured: 12 and 26 weeks
Average rating of positive change experienced in self-reported health indicators
The following health indicators are assessed: sleep quality, nutrition/diet quality, weight management, ability to manage stress, physical fitness, mental health (anxiety, depression, bipolar as applicable), and chronic diseases (cardiovascular disease, diabetes, high blood pressure, asthma, COPD, acid reflux as applicable).
Participants are asked to rate each based on if they experienced any positive change in that area due to reduced drinking; scale 1-5; 1 = not at all, 5 = very much. Greater scores on the scale indicate greater positive change experienced in that area of health.
The ratings for each health indicator are averaged across participants to generate the average rating.
Measured: 12 and 26 weeks
Depressive symptoms
Assessed via the Center of Epidemiological Studies Depression Scale (CES-D) screening questionnaire, 10 items. A score is calculated from a sum of the 10 items. Possible scores on the scale range from 0-30. Higher scores indicate greater severity of depressive symptoms, a worse outcome.
Measured: 12, 26, and 52 weeks
Anxiety
Anxiety is assessed via Generalized Anxiety Disorder 7-item scale (GAD-7). The following is asked regarding the 7 items: "Over the last two weeks, how often have you been bothered by the following problems?". The 7 items are rated on a 4-point scale (from 0-3); 0 = Not at all, 1 = Several days, 2 = More than half the days, 3 = Nearly every day.
Scores for the GAD-7 range from 0 to 21, where a higher score indicates greater severity of anxiety, a worse outcome. The following are score ranges and their associated anxiety severity: 0-4 minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.
Measured: 12, 26, and 52 weeks
Resilience
Resilience is assessed via The Brief Resilience Scale (6-item, self-report measure).
The 6 items are rated on a 5-point scale (from 1-5); 1 = Strongly disagree, 2 = Disagree, 3 = Neutral, 4 = Agree, 5 = Strongly agree.
Scores for the Brief Resilience Scale range are a result of adding the scores for the 6 items together and dividing that total by 6 (this is the average score for the items). Scores range from 1 to 5, where a higher score indicates greater resilience, a better outcome.
Measured: 12, 26, and 52 weeks
Well-being
Well-being is assessed via the WHO-5 Well-being Index (5 items) score.
The 5 items are rated on a 6-point scale (from 5-0); 5 = All of the time, 4 = Most of the time, 3 = More than half the time, 2 = Less than half the time, 1 = Some of the time, 0 = At no time.
Scores for the WHO-5 Well-being Index result from adding the scores for the 5 items together. The score ranges from 0 to 25, where a higher score indicates greater well-being and quality of life, a better outcome.
Measured: 12, 26, and 52 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 May 2024
- Study startJun 2024 (estimated)
- Primary completionJun 2025 (estimated)
- Study completionJun 2026 (estimated)
Why it stopped: Change in research priorities
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Alcohol Use, UnspecifiedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- Pivot Health Technologies Inc.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Principal investigator, Jennifer Marler, MD, Pivot Health Technologies Inc.
- Investigators
- Jennifer Marler, MD, Principal investigator, Pivot Health Technologies Inc.
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06401967
- Sponsor's protocol ID
- C-510
- Status last verified
- Jun 2024
- First submitted
- 2 May 2024
- Last updated
- 1 Jul 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 1 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility, Acceptability, and Preliminary Outcomes of a Smartphone-Based Program for Reduction in Alcohol Consumption
- ClinicalTrials.gov ID
- NCT06401967
- Acronym / sponsor ID
- C-510
- Conditions
- Alcohol Use, Unspecified
- Keywords
- alcohol reduction, digital health, mobile apps, health promotion
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Change in research priorities
- Enrolment
- 0 participants (actual)
- Lead sponsor
- Pivot Health Technologies Inc.Industry (pharma, biotech, devices)
- Study start
- Jun 2024 (estimated)
- Primary completion
- Jun 2025 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 7 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prospective, open label, single center clinical study enrolling up to 100 adult participants to evaluate the feasibility, acceptability, and preliminary outcomes of the Pivot Clear smartphone-based alcohol reduction program.
Detailed description
This is a prospective, open label, single center clinical study conducted with institutional review board (IRB) approval enrolling up to 100 adult participants who report at-risk alcohol consumption behavior and would like to reduce or eliminate alcohol consumption. The study will be performed remotely on an ambulatory basis. Participants will be asked to set up and use the Pivot Clear program. The program includes an app, personal breathalyzer, and short message service (SMS) text-based coaching with an alcohol reduction specialist. The study duration is 52 weeks. While participants will have access to the program for 52 weeks, it is expected that for most participants, most active participation in the program will be complete by 12 weeks. The primary reporting time point will be 12 weeks, with expected passive, longer-term follow-up outcomes collected at 26 weeks and 52 weeks. Participants will receive online questionnaires at intervals throughout the study (baseline, weekly for the first 12 weeks, at 26 weeks and at 52 weeks).
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pivot Clear | Experimental | Behavioral: Pivot Clear, Device: BACtrack breathalyzerA program for alcohol reduction |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- Score of ≥ 3 for women and ≥ 4 for men on the AUDIT-C at screening
- Would like to reduce or eliminate alcohol consumption
- Resident of the United States
- Able to read and comprehend English
- Owns and uses a smartphone compatible with the study app (iPhone 6 and above, operating system iOS (iPhone operating system) 15 and above, or Android 7.0 and above, operating system Android 7.0 and above)
Key exclusion criteria (9 listed)
- Currently using other support to reduce or quit alcohol, including apps, coaching, support groups, classes or quit programs
- Pregnant (self-reported)
- Self-reported past or present diagnosis of Alcohol Use Disorder (AUD)
- Self-reported past or present diagnosis of Substance Use Disorder
- Current use of the following medications: suboxone, methadone, or daily use of a benzodiazepine [including Alprazolam (e.g., Xanax), lorazepam (e.g., Ativan), clonazepam (e.g., Klonopin), diazepam (e.g., Valium), and temazepam (e.g., Restoril)]
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pivot ClearA mobile app and program for alcohol reduction. | Behavioural | Pivot Clear |
| BACtrack breathalyzerPersonal breathalyzer device that measures blood alcohol content. | Device | Pivot Clear |
Primary outcome
Proportion of participants who complete all 12 weekly follow-up assessments
Time frame: 12 weeks
Calculated as the number of participants who complete 12/12 of the weekly follow-up assessments (specifically during the first 12 weeks of the study), divided by the total number of enrolled participants.
50 secondary outcomes
Trial feasibility - enrollment
Time frame: Baseline
Trial feasibility - questionnaire completion
Time frame: 52 weeks
Average weekly alcohol consumption
Time frame: 1-12, 26, and 52 weeks
Proportion of participants with average drinks per day ≤ 2/day for men and ≤ 1/day for women
Time frame: 1-12, 26, and 52 weeks
Proportion of participants who complied with the low-risk guideline for problematic drinking
Time frame: 1-12, 26, and 52 weeks
Average daily alcohol consumption
Time frame: 1-12, 26, and 52 weeks
Average drinks per drinking day
Time frame: 1-12, 26, and 52 weeks
Proportion of participants with an AUDIT-C score below the threshold for unhealthy alcohol use in the U.S.
Time frame: 12, 26, and 52 weeks
Proportion of participants who reduced their AUDIT-C score category by by ≥ 1 risk level
Time frame: 12, 26, and 52 weeks
Proportion of participants with an AUDIT score within the "lower risk" category
Time frame: 12, 26, and 52 weeks
Proportion of participants who reduced their AUDIT score category by by ≥ 1 risk level
Time frame: 12, 26, and 52 weeks
Number of heavy drinking days
Time frame: 1-12, 26, and 52 weeks
Maximum number of drinks on any day over the timeline follow-back period
Time frame: 1-12, 26, and 52 weeks
Proportion of days abstinent
Time frame: 1-12, 26, and 52 weeks
Average duration of continuous abstinence
Time frame: 12, 26, and 52 weeks
Proportion of participants who reduced their World Health Organization (WHO) risk drinking level by ≥ 1 risk level
Time frame: 12, 26, and 52 weeks
Adverse consequence related to alcohol
Time frame: 12, 26, and 52 weeks
Drinking motivations
Time frame: 12, 26, and 52 weeks
Desire to change drinking habits
Time frame: Baseline
Reasons for desired change in drinking habits
Time frame: Baseline
Readiness to change
Time frame: 4 and 12 weeks
Expected success to change drinking habits
Time frame: 4 and 12 weeks
Expected difficulty maintaining reduction/abstinence
Time frame: 4 and 12 weeks
Satisfaction with current drinking behavior
Time frame: 12, 26, and 52 weeks
User feedback - set up and getting started with the program
Time frame: 4 weeks
User satisfaction - Net Promoter Score
Time frame: 4, 12, and 26 weeks
User satisfaction - how use of the program has affected alcohol consumption
Time frame: 5 weeks
User satisfaction - effectiveness of the program
Time frame: 12 weeks
User satisfaction - whether the program helped the participant maintain alcohol reduction
Time frame: 12, 26, and 52 weeks
User satisfaction - program's ability to help someone reduce or quit alcohol
Time frame: 10 weeks
User satisfaction - perceived need for the program
Time frame: 4 weeks
User satisfaction - effect of program on motivation to reduce/abstain
Time frame: 3 weeks
User feedback - initial reactions to program design, specific program features including the breathalyzer, coaching, lessons, and drink tracking
Time frame: 1 week
User feedback - program design, specific program features including the breathalyzer, coaching, lessons, and drink tracking
Time frame: 2, 3, 5, and 12 weeks
User satisfaction - aspects of program participant enjoyed most/least
Time frame: 12 weeks
User feedback - possible future program features
Time frame: 12 weeks
Use of other alcohol reduction or abstinence tools (apps, counseling, medications, etc.)
Time frame: 11, 26, and 52 weeks
Engagement with the program - app openings
Time frame: 26 weeks
Engagement with program - number of days with app openings
Time frame: 26 weeks
Engagement with program - number of weeks with app openings
Time frame: 26 weeks
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Jul 2024.
Related trials for Alcohol Use, Unspecified
Recruiting
Partnering to Enhance Emerging Adults' Response to Programs
Alcohol Use, Unspecified
Recruiting
CARS: Cannabis and Alcohol Reduction Study
Cannabis Use, Alcohol Use, Unspecified
Recruiting
Drinking, Acetate, and Stress
Alcohol Use Disorder, Alcohol Use, Unspecified
Recruiting
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Cannabis Use, Alcohol Use, Unspecified
Not yet recruiting
Whole Selves User Testing and Feasibility Study
Alcohol Use, Unspecified, Relationship, Social
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jennifer Marler, MD principal investigator
Pivot Health Technologies Inc.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pivot Clear and BACtrack breathalyzer in people with Alcohol Use, Unspecified, run by Pivot Health Technologies Inc. at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 1 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of participants who complete all 12 weekly follow-up assessments (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2024.